Alcohol-Attributable Cancer: Update From the Global Burden of Disease 2021 Study

By sjmartinez • April 28, 2025

Danpanichkul P, Pang Y, Díaz LA, White TM, Sirimangklanurak S, Auttapracha T, Suparan K, Syn N, Jatupornpakdee P, Saowapa S, Ng CH, Kaewdech A, Lui RN, Fallon MB, Yang JD, Louvet A, Noureddin M, Liangpunsakul S, Jepsen P, Lazarus JV, Arab JP, Wijarnpreecha K. Alcohol-Attributable Cancer: Update From the Global Burden of Disease 2021 Study. Aliment Pharmacol Ther. 2025 Apr 27. doi: 10.1111/apt.70163. Epub ahead of print. PMID: 40287931.

Tags: Alcohol, Alcoholic liver disease, Cancer, Cedars Sinai DoM, Digestive Diseases, Epidemiology, oncology, public health, Publications

Related Posts

Deep Learning with Domain Randomization in Image and Feature Spaces for Abdominal Multiorgan Segmentation on CT and MRI Scans

Shi Y, Wang L, Qureshi TA, Deng Z, Xie Y, Li D. Deep Learning with Domain Randomization in Image and Feature Spaces for Abdominal Multiorgan[...]

Accelerating CEST MRI With Deep Learning-Based Frequency Selection and Parameter Estimation

Shen C, Cheema K, Xie Y, Ruan D, Li D. Accelerating CEST MRI With Deep Learning-Based Frequency Selection and Parameter Estimation. NMR Biomed. 2025 Jul;38(7):e70068.[...]

Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA phase 3 randomized clinical trial

Lau G, Sangro B, Cheng AL, Kudo M, Kelley RK, Tak WY, Gasbarrini A, Reig M, Lim HY, Tougeron D, De Toni EN, Tam VC,[...]